<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Filed Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 1, 2000
----------------
ILEX ONCOLOGY, INC.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware
--------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-23413 94-3123681
--------------------------------------------------------------------------------
(Commission File Number) (IRS Employer Identification No.)
4545 Horizon Hill Blvd., San Antonio, Texas 78229
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(210) 949-8200
--------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
11550 I.H. 10 West, Suite 100, San Antonio, Texas 78230
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE> 2
Item 5. Other Events.
On November 1, 2000, ILEX Oncology, Inc. issued a press release
announcing its third quarter results of operations. The press release is
attached hereto as Exhibit 99.1 and incorporated herein by reference. The
foregoing description is qualified by reference to such exhibit.
Item 7 (c). Exhibits.
Exhibit 99.1 Press Release dated November 1, 2000.
-2-
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ILEX ONCOLOGY, INC.
By /s/ Gregory L. Weaver
-----------------------------------
Gregory L. Weaver
Vice President and Chief Financial
Officer
DATE: November 1, 2000
<PAGE> 4
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
EXHIBIT
NUMBER DESCRIPTION
------- -----------
<S> <C>
99.1 Press Release dated November 1, 2000.
</TABLE>
